Diabetes-Metabolism Research and Reviews

Papers
(The TQCC of Diabetes-Metabolism Research and Reviews is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
242
Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 2035147
The circadian syndrome is a predictor for cognition impairment in middle‐aged adults: Comparison with the metabolic syndrome106
Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking100
Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)100
Central and Peripheral Sensitivity to Thyroid Hormones Correlate to Metabolically Obesity Phenotypes in Chinese Euthyroid Adults: A Cross‐Sectional Study70
Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials67
The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application65
Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort59
Cover Image56
Issue Information56
Longitudinal cardiovascular health measured by life's essential 8 metrics with incident diabetes: A 13‐year prospective cohort study52
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis51
50
Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes49
Stuttering in adolescence and the risk for dysglycemia in early adulthood47
Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes46
The relationship between neonatal hypoglycaemia and cord blood C‐peptide levels in neonates of birthing individuals with type 1 diabetes43
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials35
A variation in SORBS1 is associated with type 2 diabetes and high‐density lipoprotein cholesterol in Chinese population35
Classification of foot ulcers in people with diabetes: A systematic review34
Development of a Chinese‐Specific Clinical Model to Predict Maturity‐Onset Diabetes of the Young34
Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes34
Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China32
Withdrawal: Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquill32
31
Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years31
31
SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all‐cause mortality, in Caucasians with type 2 diabetes: A 13‐year observational study30
Association of thyroid stimulating hormone and time in range with risk of diabetic retinopathy in euthyroid type 2 diabetes29
Cover Image29
Pep19: A Novel Approach for Reducing Visceral Fat and Improving Sleep Quality in Obese Adults—Results From an Early‐Stage Clinical Trial27
Diagnosis of infection in the foot of patients with diabetes: A systematic review27
A multidisciplinary team reduces in‐hospital clinical complications and mortality in patients with diabetic foot ulcers27
N‐Lactoyl Amino Acids: Emerging Biomarkers in Metabolism and Disease26
Fibre‐Enriched High‐Carbohydrate (FEHC) Diet Modulates Inflammation Without Affecting Bone Health in Older Women With Obesity: A Randomised Clinical Trial26
Reduced early response to SARS‐CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow‐up study: The CoVaDiab study I26
Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review25
Prevention of foot ulcers in persons with diabetes at risk of ulceration: A systematic review and meta‐analysis25
Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabet25
Insulin resistance is more frequent in type 1 diabetes patients with long disease duration23
23
Insulin requirements during pregnancy in women with type 1 diabetes treated with insulin pump23
Chinese Visceral Adiposity Index Trajectory and Stroke in Prediabetes and Diabetes: A Prospective Cohort Study23
Diabetes Study of Children of Diverse Ethnicity and Race: Study design23
Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index22
Muscle‐to‐fat ratio in children and adolescents with type 1 diabetes in predicting glycaemic control and partial clinical remission22
Incretin‐Based Adjunct to Background Insulin Treatment for Managing Body Weight Excess in Type 1 Diabetes: An Expert Opinion Viewpoint From the Italian Association of Clinical Endocrinologists21
Caries‐related salivary parameters and oral microbial flora in patients with type 1 diabetes: A meta‐analysis21
Is breakfast consumption detrimental, unnecessary, or an opportunity for health promotion? A review of cardiometabolic outcomes and functional food choices21
Insulin action and secretion independent of traditional risk factors predict new‐onset type 2 diabetes in Iraqi and Swedish born citizens – The MEDIM cohort study20
Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic control20
Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION‐1 study20
Early treatment with dipeptidyl‐peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score‐matched cohort study20
Fasting C‐peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality19
Cover Image19
Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?18
Increased Risk of Type 1 Diabetes in Boys Under the Age of 5 Years During COVID‐19 Lockdowns in Finland, Sweden and Stanford, CA, USA—An Observational Multicenter Study18
Changes in smoking status, amount of smoking and their relation to the risk of microvascular complications in men with diabetes mellitus18
Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study18
Association between severe hypoglycaemia and risk of dementia in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis17
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group17
Use of the SINBAD score as a predicting tool for major adverse foot events in patients with diabetic foot ulcer: A French multicentre study17
Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (C17
Prediabetes and risk of stroke and its subtypes by hypertension status17
Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent17
A Century of Prolactin: Emerging Perspectives as a Metabolic Regulator17
17
Metabolic–Bariatric Surgery Reduces Pancreatic Cancer Risk: A Meta‐Analysis of Over 3.7 Million Adults, Independent of Type 2 Diabetes Status16
Association of Sudomotor Dysfunction With Risk of Subclinical Carotid Atherosclerosis in Patients With Type 2 Diabetes16
Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease16
Biochemical predictors of diabetic foot osteomyelitis: A potential diagnostic role for parathormone16
The Use of Omics in Untangling the Effect of Lifestyle Factors in Pregnancy and Gestational Diabetes: A Systematic Review16
Time In Tight Range in children and adolescents with type 1 diabetes: A cross‐sectional observational single centre study evaluating efficacy of new advanced technologies16
Acute diabetic foot in post kidney transplantation patients receiving chronic immunosuppression—clinical presentation and outcomes16
Use of an Advanced Hybrid Closed Loop System During Marathon Running: Case Examples and Clinical Implications15
Issue Information15
Current Progress and Challenges in the Development of Pharmacotherapy for Metabolic Dysfunction‐Associated Steatohepatitis15
15
Comparative efficacy of growth factor therapy in healing diabetes‐related foot ulcers: A network meta‐analysis of randomized controlled trials15
A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?15
Performance of non‐invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: A systematic review15
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta‐Analysis14
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15)14
A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease14
The therapeutic potential of an allosteric non‐competitive CXCR1/2 antagonist for diabetic nephropathy14
Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta‐analysis14
The role of autophagy in insulin resistance and glucolipid metabolism and potential use of autophagy modulating natural products in the treatment of type 2 diabetes mellitus14
Withdrawal: Prevalence of type 2 diabetes in Argentina 1979‐201214
Type 1 diabetes could begin with alterations in innate anti‐viral immunity, which are already at this stage associated with HLA risk haplotypes13
Dyslipidemia and SARS‐CoV‐2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in Japan13
Cover Image13
Issue Information13
Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Mineral Density and Bone Turnover Markers: A Meta‐Analysis13
Conservative surgery and postoperative antibiotics guided by bone biopsies for diabetic foot osteomyelitis. Comments on Nguyen S, et al. conservative surgical treatment for metatarsal osteomyelitis in13
Diagnosis and treatment of active charcot neuro‐osteoarthropathy in persons with diabetes mellitus: A systematic review13
Definitions and criteria for diabetes‐related foot disease (IWGDF 2023 update)12
Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta‐analysis12
Albumin‐To‐Creatinine Ratio Underestimates True 24‐Hour Albuminuria in Obesity: Clinical Relevance for Vascular Risk Stratification12
Temporal Trends in the Burden of Diabetes and Its Risk Factors Across the Western Pacific Region Between 1990 and 2044: A Systematic Analysis of the Global Burden of Disease Study 201912
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes12
Time‐dependent risk of fracture in adults with type 2 diabetes receiving anti‐diabetic drug: A one‐stage network meta‐analysis11
Obesogenic environments as major determinants of a disease: It is time to re‐shape our cities11
Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis11
Association between type 2 diabetes and skeletal muscle quality assessed by abdominal computed tomography scan11
Predictors of efficacy of Sodium‐GLucose Transporter‐2 inhibitors and Glucagon‐Like Peptide 1 receptor agonists: A retrospective cohort study11
Offloading and adherence through technological advancements: Modern approaches for better foot care in diabetes11
Diabetes, COVID‐19, and questions unsolved11
Unravelling the Metabolic Underpinnings of Gestational Diabetes Mellitus: A Comprehensive Mendelian Randomisation Analysis Identifying Causal Metabolites and Biological Pathways11
Skin Autofluorescence as a Predictor of Bone Fragility in Type 1 Diabetes: A Critical Appraisal of the Evidence11
Cover Image10
Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight10
Recommendations for the Management of Diabetes During Ramadan Applying the Principles of the ADA/ EASD Consensus: Update 202510
Third dose of COVID‐19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy10
The transiency of metabolically healthy obesity: Metabolic decline and atherosclerotic risk10
Association of alcohol drinking with incident type 2 diabetes and pre‐diabetes: The Guangzhou Biobank Cohort Study10
Long‐Term Effectiveness of Once‐Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real‐World Study10
Vitamin D and diabetic peripheral neuropathy: A multi‐centre nerve conduction study among Chinese patients with type 2 diabetes10
Interaction effects of MTHFR C677T and A1298C polymorphisms with maternal glycated haemoglobin levels on adverse birth outcomes10
Adherence to an energy‐restricted Mediterranean diet is associated with the presence and burden of carotid atherosclerosis in people with type 1 diabetes10
Does a prior diagnosis of infectious disease confer an increased risk of latent autoimmune diabetes in adults?10
Searching the Crystal Ball for Tailored GLP‐1 Receptor Agonists Treatment in Type 2 Diabetes and Obesity10
Autoimmune Type 1 Diabetes in the Era of Disease‐Modifying Immune Therapy10
0.16293096542358